Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.33 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.33 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4657455 | 0.71 | TAAR1 (0.36) | MAPTALDH1A1MEN1KMT2APOLB | |
| SCHEMBL12775851 | 0.70 | KDM4E (0.47) | KDM4EHSD17B10MAPTHIF1AALDH1A1 | |
| SCHEMBL16533079 | 0.70 | MAPT (0.47) | KDM4EHSD17B10MAPTHIF1AALDH1A1 | |
| SCHEMBL4657492 | 0.70 | IDO1 (0.36) | KDM4EALDH1A1 | |
| SCHEMBL4657516 | 0.67 | KDM4E (0.37) | KDM4EHSD17B10MAPTALDH1A1HPGD | |
| SCHEMBL4657447 | 0.66 | ATM (0.40) | HIF1AALDH1A1SMN1; SMN2 | |
| SCHEMBL25399698 | 0.65 | MAPT (0.57) | KDM4EHSD17B10MAPTHIF1AALDH1A1 | |
| SCHEMBL762893 | 0.65 | KMT2A (0.56) | KDM4EHSD17B10MAPTHIF1AALDH1A1 | |
| SCHEMBL2805013 | 0.65 | KDM4E (0.52) | KDM4EHSD17B10MAPTHIF1AALDH1A1 | |
| SCHEMBL7718402 | 0.65 | KDM4E (0.52) | KDM4EHSD17B10MAPTHIF1AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090136551-A1 | Substituted Dicyanoalkanes For Combating Animal Pests | BASF AKTIENGESELLSCHAFT (DE) | 2009-05-28 | — | — | US | disclosed |
| EP-1912958-A1 | SUBSTITUTED MALONONITRILE COMPOUNDS FOR COMBATING ANIMAL PESTS | BASF SE (DE) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007017414-A1 | SUBSTITUTED MALONONITRILE COMPOUNDS FOR COMBATING ANIMAL PESTS | BASF SE (DE) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090136551-A1 | Substituted Dicyanoalkanes For Combating Animal Pests | DDT, AAK1, DCLK3 | KDM4E 2405/4885HSD17B10 1545/4885MAPT 2408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.